MyBlueDotsNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea MyBlueDots4 weeks ago01 mins MILAN, Italy & MORRISTOWN, New Jersey & SEOUL, Republic of Korea–(BUSINESS WIRE)—- $NWRN #schizophrenia–Newron and Myung In Pharm, South Korea’s leading specialist CNS pharma company, announce license agreement for evenamide in South Korea. Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots6 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots6 hours ago 0